mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.088 |
0.2 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |